Quanterix Corporation

The business, in plain English

Quanterix Corporation booked $139M of revenue in FY2025 in the Healthcare sector and kept 46.8% of it as gross profit — a solid-margin business by that measure. After every other cost, −77.1% of each revenue dollar reached the bottom line.

Across the filed record, revenue grew from $17.6M (FY2016) to $139M (FY2025) — about 25.8% a year compounded over 9 years.

It earned −37.3% on invested capital in the latest filed year, FY2025. Across the full 7-year measurable filed record, median ROIC was −78.1%. Over the v3 recent window (7 measurable filed years), median ROIC was −78.1%. The Returns on Capital filter above scores it 0/100.

QTRX's latest filed year, FY2025, doesn't disclose total debt in a form the methodology can use, so current leverage is treated as unmeasured — never assumed to be zero.

Put together: Pricing Power is the strongest of the five filters (68/100) and Returns on Capital the weakest (0/100), which is how QTRX lands at 39/100 — a None moat.

This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.